Proximity to residential and workplace pesticides application and the risk of progression of Parkinson's diseases in Central California S Li, B Ritz, Y Gong, M Cockburn, AD Folle, I Del Rosario, Y Yu, K Zhang, ... Science of The Total Environment 864, 160851, 2023 | 23 | 2023 |
Inadequate use of newer treatments and glycemic control by cardiovascular risk and sociodemographic groups in US adults with diabetes in the NIH precision medicine initiative … D Devineni, M Akbarpour, Y Gong, ND Wong Cardiovascular Drugs and Therapy 38 (2), 347-357, 2024 | 10 | 2024 |
Agricultural paraquat dichloride use and Parkinson’s disease in California’s Central Valley KC Paul, M Cockburn, Y Gong, J Bronstein, B Ritz International Journal of Epidemiology 53 (1), dyae004, 2024 | 7 | 2024 |
Dyslipidemia treatment and lipid control in US adults with diabetes by sociodemographic and cardiovascular risk groups in the NIH Precision Medicine Initiative All of Us … M Akbarpour, D Devineni, Y Gong, ND Wong Journal of clinical medicine 12 (4), 1668, 2023 | 4 | 2023 |
Correction: Akbarpour et al. Dyslipidemia Treatment and Lipid Control in US Adults with Diabetes by Sociodemographic and Cardiovascular Risk Groups in the NIH Precision … M Akbarpour, D Devineni, Y Gong, ND Wong Journal of Clinical Medicine 13 (4), 1155, 2024 | | 2024 |
Disparities in Composite Cardiovascular Risk Factor Control in US Adults With Diabetes in the NIH Precision Medicine Initiative All of Us Research Program FD Golden, Y Gong, ND Wong Circulation 148 (Suppl_1), A14786-A14786, 2023 | | 2023 |
Relation of Medical and Social Determinants of Health to Use of Guideline-Directed Medical Therapy for Heart Failure With Reduced Ejection Fraction in the All of Us Research … TK Do, K Grace, Y Gong, D Devineni, D Lombardo, ND Wong, A Lee Circulation 148 (Suppl_1), A12492-A12492, 2023 | | 2023 |
Interplay of Cardiovascular Risk Factors, Comorbidities, Demographics, and Social Determinants of Health on Adherence to Guideline Directed Medical Therapies in Heart Failure … T Do, K Grace, Y Gong, D Devineni, D Lombardo, ND Wong, A Lee Circulation 148 (Suppl_1), A14848-A14848, 2023 | | 2023 |
Newer Treatments and Glycemic Control in US Adults With Diabetes Across Risk Groups, Sex, and Ethnicity: The NIH Precision Medicine Initiative (All Of Us Study) D Devineni, M Akbarpour, Y Gong, ND Wong American Heart Journal 242, 162, 2021 | | 2021 |
Statin and Icosapent Ethyl Use and Lipid Control in US Adults with Diabetes According to DM Risk Groups, Sex and Ethnicity in the NIH Precision Medicine Initiative All of Us Study M Akbarpour, D Devineni, Y Gong, ND Wong American Heart Journal 242, 164-165, 2021 | | 2021 |
Cardiovascular Risk Factor Control and Treatment Across the Spectrum of Patients with Atherosclerotic Cardiovascular Disease: The Precision Medicine Initiative-All of Us Study Y Gong, ND Wong Circulation 144 (Suppl_1), A10361-A10361, 2021 | | 2021 |
Risk Factor control and treatment among People with Atherosclerotic Cardiovascular Disease in the All of Us Study Y Gong University of California, Los Angeles, 2021 | | 2021 |
The Role of Inflammation and Psycho-Behavioral Factors as Mediators Between Acculturation and Time to Incident Dementia Among Older Mexican Americans RA Nianogo, RD Hays, Y Gong, Y Yu, B Ritz, OK Duru Journal of Alzheimer's Disease, 1-11, 0 | | |